Dementia & Alzheimer Disease Market Research and Report 2025


Posted November 4, 2020 by Barbarhinkle

Global Dementia & Alzheimer Disease Market report helps to recognize the most recent improvements, share, and systems utilized by the significant market.

 
dementia & alzheimer disease market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. According to the World Health Organization, cost of treatment of dementia is more than USD 604 billion per year. This includes the cost of providing health and social care as well the reduction or loss of income of people with dementia and their caregivers.

Market Definition:

The most common cause of dementia is Alzheimer’s disease. Dementia is a group of co-occurring signs and symptoms that includes progressive worsening of intellectual role.  Dementia defines number of symptoms which contains memory loss and problems with thinking, problem-solving or language. These types of indications generally happen when the brain is injured by particular diseases, counting Alzheimer’s illness Numerous cognitive abilities are reduced with dementia, including language, attention, memory, reasoning, visuospatial function, decision making, orientation and others. People with dementia and cognitive impairments often suffer with change in personality, emotional regulation, and social behaviors. Significantly, the intellectual and behavioral changes occur with dementia that can interfere with work, social activities, relationships and damage a person’s ability to perform routine daily activities (e.g., driving, shopping, housekeeping, cooking, managing finances, and personal care). Common symptoms of dementia include the gradual loss of memory, decline in communication skills and difficulty with thinking and reasoning.

NOTE: Our team is studying COVID19 and its impact on various industry verticals and wherever required we will be considering Covid19 footprints for a better analysis of markets and industries. Kindly get in touch for more details.

Market Drivers and Restraints:

Growing prevalence of Alzheimer’s disease

Increasing awareness about the treatment of Alzheimer’s disease

High treatment cost

Side effects of the disease treatment

Key Players: Global Dementia & Alzheimer Disease Market

Ono Pharmaceutical, Daiichi Sankyo Company Limited, H Lundbeck A/S, Johnson & Johnson, Eisai Co Ltd., Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG, Eisai Co. Ltd., Lundbeck A/S and Teva Pharmaceuticals Industries Ltd., Eli Lilly and Company, TauRx Pharmaceuticals Ltd, VTV Therapeutics, Hoffman-La Roche Ltd., AstraZeneca plc, and AC Immune

MAJOR TOC OF THE REPORT

Chapter One: Dementia & Alzheimer Disease Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Dementia & Alzheimer Disease Market Competition, by Players

Chapter Four: Global Dementia & Alzheimer Disease Market Size by Regions

Chapter Five: Global Dementia & Alzheimer Disease Market Revenue by Countries

Chapter Six: Global Dementia & Alzheimer Disease Market Revenue by Drug Class

Chapter Seven: Global Dementia & Alzheimer Disease Market Revenue by  Distribution Channel

Chapter Eight: Global Dementia & Alzheimer Disease Market Revenue by Geography

Key Developments in the Market: 
In January 2018, Dthera Sciences (U.S.), launched ReminX, which is an artificial-intelligence-powered consumer health product designed to digitally deliver reminiscence therapy to individuals suffering from Alzheimer's and other dementias.

In July 2018, ADI (U.S.) and Global Coalition on Aging (GCOA) (U.S.) launched the Dementia Innovation Readiness Index during ADI’s 33rd International Conference in Chicago. This Index can be used to analyze the readiness of countries to develop and organize dementia solutions into their healthcare, policy and social frameworks.

Primary Respondents:
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others
Key Questions Answered in Report:

What is the key to the Dementia & Alzheimer Disease Market?

What will the Dementia & Alzheimer Disease Market Demand and what will be Growth?

What are the latest opportunities for Dementia & Alzheimer Disease Market in the future?

What are the strengths of the key players?

NOTE: Our team is studying COVID19 and its impact on various industry verticals and wherever required we will be considering Covid19 footprints for a better analysis of markets and industries. Kindly get in touch for more details.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

 
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Data Bridge Market Research
Phone 01888387281
Business Address Office Number 402,
Amanora Chambers,
Country India
Categories Business , Health
Tags business study and forecast and sale , market by application , market demand and research , market size
Last Updated November 4, 2020